0001827672-23-000043.txt : 20231020 0001827672-23-000043.hdr.sgml : 20231020 20231020164121 ACCESSION NUMBER: 0001827672-23-000043 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20231018 FILED AS OF DATE: 20231020 DATE AS OF CHANGE: 20231020 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Azamian Bobak R. CENTRAL INDEX KEY: 0001827672 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39614 FILM NUMBER: 231337520 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD, SUITE 160 CITY: IRVINE STATE: CA ZIP: 92618 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tarsus Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001819790 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 814717861 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 BUSINESS PHONE: (949) 409-9820 MAIL ADDRESS: STREET 1: 15440 LAGUNA CANYON ROAD CITY: IRVINE STATE: CA ZIP: 92618 4 1 wk-form4_1697834436.xml FORM 4 X0508 4 2023-10-18 0 0001819790 Tarsus Pharmaceuticals, Inc. TARS 0001827672 Azamian Bobak R. C/O TARSUS PHARMACEUTICALS, INC. 15440 LAGUNA CANYON ROAD, SUITE 160 IRVINE CA 92618 1 1 0 0 President/CEO and Board Chair 1 Common Stock 2023-10-18 4 S 0 8000 13.24 D 886106 I By the Bobak Azamian Living Trust established April 16, 2018 Common Stock 8597 D The sales reported in this Form 4 were effected by an automatic sale pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 23, 2023. The price reported in column 4 is a weighted average price. The shares were pooled and sold in multiple transactions at prices ranging from $13.00 to $13.65. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The Reporting Person is the trustee of the Bobak Azamian Living Trust, established April 16, 2018 and has voting and dispositive power with respect to these shares. /s/ Jeffrey Farrow, Attorney-in-Fact 2023-10-20